Tolvaptan efficacy and drug-drug interactions

被引：1

作者：

Piccica, Matteo ^{[1
]}

Basile, Gregorio ^{[1
]}

Bartalesi, Filippo ^{[2
]}

Parenti, Gabriele ^{[3
]}

Farese, Alberto ^{[2
]}

Buci, Lisa ^{[3
]}

Corti, Giampaolo ^{[1
,2
]}

Bartoloni, Alessandro ^{[1
,2
]}

Peri, Alessandro ^{[4
]}

机构：

[1] Univ Florence, Dept Expt & Clin Med, Florence, Italy

[2] Careggi Univ Hosp, Unit Infect & Trop Dis, Florence, Italy

[3] Careggi Univ Hosp, Dept Endocrinol, Unit Pituitary Dis & Sodium Alterat, Viale Pieraccioni 6, I-50139 Florence, Italy

[4] Univ Florence, Pituitary Dis & Sodium Alterat Unit, Dept Endocrinol, AOU Careggi, Florence, Italy

来源：

MINERVA ENDOCRINOLOGICA | 2020年 / 45卷 / 03期

关键词：

D O I：

10.23736/S0391-1977.20.03189-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：264 / 265

页数：2

共 50 条

[21] Dolutegravir drug-drug interactions
Mondleki, E.
Maartens, G.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2022, 112 (03): : 194 - 195
[22] Pharmacodynamic Drug-Drug Interactions
Niu, Jin
Straubinger, Robert M.
Mager, Donald E.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1395 - 1406
[23] Drug-drug interactions with raltegravir
Burger D.M.
European Journal of Medical Research, 14 (Suppl 3) : 17 - 21
[24] Multiple drugsVarious toxicities, drug-drug pharmacokinetic interactions and lack of efficacy
Reactions Weekly, 2024, 2019 (1) : 355 - 356
[25] Using unusual drug-drug interactions to maximize voriconazole treatment efficacy
Boglione-Kerrien, Christelle
Verdier, Marie-Clemence
Gautier-Veyret, Elodie
Hennart, Benjamin
Belaz, Sorya
Revest, Matthieu
Lemaitre, Florian
MEDECINE ET MALADIES INFECTIEUSES, 2019, 49 (07): : 555 - 557
[26] Multiple drugsDecreased drug levels following drug-drug pharmacokinetic interactions and lack of efficacy
Reactions Weekly, 2024, 1998 (1) : 320 - 320
[27] Adverse drug reactions related to drug-drug interactions: lower severity level of drug-drug interactions and pharmacodynamic interactions are oversighted
Kheloufi, F.
Duval, M.
Rouby, F.
Ponte, J.
Blin, O.
Default, A.
Micallef, J.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89
[28] DRUG-DRUG INTERACTIONS AS AN ISSUE IN DRUG DEVELOPMENT
Jochemsen, R.
Bouzom, F.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 2 - 2
[29] Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions
Choi, Min-Koo
Song, Im-Sook
PHARMACEUTICS, 2021, 13 (05)
[30] DRUG UTILIZATION AND POTENTIAL DRUG-DRUG INTERACTIONS
LAVENTURIER, MF
TALLEY, RB
HEFNER, DL
KENNARD, LH
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1976, 16 (02): : 77 - 81

← 1 2 3 4 5 →